Issam Zineh has joined the US Food and Drug Administration as associate director for genomics in the Office of Clinical Pharmacology.
Zineh was previously associate director of the Pharmacogenomics Center at the University of Florida, where he was also an assistant professor of clinical practice.
Zineh replaces Felix Frueh, who left the FDA earlier this year to join Medco Health Solutions as VP of research and development for personalized medicine.
Following last week’s merger of Applied Biosystems and Invitrogen to create Life Technologies, the combined firm has appointed three former directors of ABI to its board: Arnold Levine, George Adam, and William Longfield.
Levine will serve as a member of the board’s Science and Technology Committee, Adam will serve as a member of the Audit Committee, and Longfield will serve as a member of the Compensation and Organizational Committee.
In addition, as previously announced, Life Technologies appointed Mark Stevenson, formerly the president and COO of ABI, to the position of president and COO of the combined firm.
The company disclosed in an SEC filing last week that Stevenson will receive an annual salary of $650,000 with options to purchase up to $3.6 million in shares. He will also receive a cash payment of $6,798,040 related to the termination of his employment agreement with ABI.
Michael Singer has joined Exact Sciences’ board of directors. Singer is CEO of the BrainScope Company, and he has served as an executive at Revolution LLC, at Microsoft, and at Data Critical.
Frederick Pollock has been named VP of corporate development at High Throughput Genomics. Pollock previously was involved in management, sales, and business development at Affymetrix, and before that he spent 11 years at Amersham Pharmacia Biotech.
Haig Kazazian, a professor of medicine at the University of Pennsylvania School of Medicine, has been awarded the Allan Award from the American Society of Human Genetics. Kazazian won the award for his discoveries of the association of chromosome haplotypes with disease-causing mutations and in the field of gene jumping. The award carries with it a $10,000 prize.